Targeting enzymes for pharmaceutical development : methods and protocols
Author(s)
Bibliographic Information
Targeting enzymes for pharmaceutical development : methods and protocols
（Methods in molecular biology / John M. Walker, series editor, 2089）（Springer protocols）
Humana Press, c2020
Available at / 1 libraries
-
No Libraries matched.
- Remove all filters.
Note
Includes bibliographical references and index
Description and Table of Contents
Description
This volume explores detailed methods and experimental protocols evaluating the effect of a compound or a mixture of compounds on the action of enzymes that are significant targets in pharmaceuticals. Consisting of three sections, the book delves into recent biocomputing and bioinformatics protocols, state-of-the art modern biophysical, electrophoretic, and chromatographic methods and high-throughput screening approaches, as well as detailed protocols and examples of the inhibition analysis and evaluation of selected enzymes. Written for the highly successful Methods in Molecular Biology series, chapters include introductions to their respective topics, lists of the necessary materials and reagents, step-by-step, readily reproducible laboratory protocols, and tips on troubleshooting and avoiding known pitfalls.
Authoritative and cutting-edge, Targeting Enzymes for Pharmaceutical Development: Methods and Protocols serves as a vital reference for academics and industry professionals working on expanding our understanding of the wide range of important enzyme targets.
Table of Contents
1. In Silico Laboratory: Tools for Similarity-Based Drug Discovery
Samo Lesnik and Janez Konc
2. The In Silico Fischer Lock-and-Key Model: The Combined Use of Molecular Descriptors and Docking Poses for the Repurposing of Old Drugs
Marco Tutone and Anna Maria Almerico
3. Determination of Half-Maximal Inhibitory Concentration of an Enzyme Inhibitor
Nikolaos Georgakis, Elisavet Ioannou, Christina Varotsou, Geogios Permetis, Evangelia G. Chronopoulou, and Nikolaos E. Labrou
4. Applications of Differential Scanning Fluorometry and Related Technologies in Characterization of Protein-Ligand Interactions
Bolormaa Baljinnyam, Michael Ronzetti, Adam Yasgar, and Anton Simeonov
5. High-Throughput Differential Scanning Fluorimetry of GFP-Tagged Proteins
Alanna E. Sorenson and Patrick M. Schaeffer
6. Enzyme-Ligand Interaction Monitored by Synchrotron Radiation Circular Dichroism
Rohanah Hussain, Charlotte S Hughes, and Giuliano Siligardi
7. Measuring Small Molecule Binding to Escherichia coli AcrB by Surface Plasmon Resonance
Steven W. Polyak, Rumana Mowla, and Henrietta Venter
8. Systematic Screening of Viral Entry Inhibitors Using Surface Plasmon Resonance
Penmetcha K.R. Kumar
9. Screening of Beta-Secretase Inhibitors by Capillary Electrophoresis-Mass Spectrometry
Jan Schejbal, Roman Reminek, and Zdenek Glatz
10. Electrophoretic Mobility Shift Assays with GFP-Tagged Proteins (GFP-EMSA)
Alanna E. Sorenson and Patrick M. Schaeffer
11. On-Line Enantioselective Capillary Electrophoretic Method for Screening Cytochrome P450 3A4 Inhibitors
Roman Reminek, Zdenek Glatz, and Wolfgang Thormann
12. Enzymatic Bioautographic Methods
I. Ayelen Ramallo, Mario O. Salazar, and Ricardo L.E. Furlan
13. High-Throughput Assessment of Metabolism-Induced Toxicity of Compounds on a 384-Pillar Plate
Soo-Yeon Kang, Kyeong-Nam Yu, Pranav Joshi, and Moo-Yeal Lee
14. Droplet-Based Microfluidics Methods for Detecting Enzyme Inhibitors
Abraham Ochoa, Frida Trejo, and Luis F. Olguin
15. Ligand Fishing: An Approach for the Discovery Inhibitors from Complex Biological Mixtures
Evangelia G. Chronopoulou, Christina Varotsou, Nikolaos Georgakis, Georgios Permetis, Elisavet Ioannou, and Nikolaos E. Labrou
16. HMG-CoA Reductase as Target for Drug Development
Baskaran Gunasekaran and Mohd Yunus Shukor
17. Lipoxygenases as Targets for Drug Development
Xiao-Yuan Mao
18. Cholinesterase as a Target for Drug Development in Alzheimer's Disease
Piyoosh Sharma, Manish Kumar Tripathi, and Sushant Kumar Shrivastava
by "Nielsen BookData"